Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice

IR Dunay, K Gajurel, R Dhakal… - Clinical microbiology …, 2018 - Am Soc Microbiol
Primary Toxoplasma gondii infection is usually subclinical, but cervical lymphadenopathy or
ocular disease can be present in some patients. Active infection is characterized by …

Treatment of toxoplasmosis: Current options and future perspectives

N Konstantinovic, H Guegan, T Stäjner, S Belaz… - Food and waterborne …, 2019 - Elsevier
Toxoplasmosis is a worldwide parasitic disease infecting about one third of humans, with
possible severe outcomes in neonates and immunocompromised patients. Despite …

Advances and challenges in understanding cerebral toxoplasmosis

D Schlüter, A Barragan - Frontiers in immunology, 2019 - frontiersin.org
Toxoplasma gondii is a widespread parasitic pathogen that infects over one third of the
global human population. The parasite invades and chronically persists in the central …

[HTML][HTML] Toxoplasmosis in transplant recipients, Europe, 2010–2014

F Robert-Gangneux, V Meroni, D Dupont… - Emerging infectious …, 2018 - ncbi.nlm.nih.gov
Transplantation activity is increasing, leading to a growing number of patients at risk for
toxoplasmosis. We reviewed toxoplasmosis prevention practices, prevalence, and outcomes …

Management of toxoplasmosis in transplant recipients: an update

C Dard, P Marty, MP Brenier-Pinchart… - Expert review of anti …, 2018 - Taylor & Francis
Introduction. Toxoplasmosis is a life-threatening parasitic disease for hematopoietic stem
cell transplant (HSCT) and solid organ transplant (SOT) recipients. The risk of toxoplasmosis …

Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations

K Gajurel, R Dhakal, JG Montoya - Current opinion in infectious …, 2015 - journals.lww.com
Toxoplasma prophylaxis in haematopoietic cell transplant rec... : Current Opinion in Infectious
Diseases Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the …

Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell …

R Aerts, V Mehra, AH Groll, R Martino… - The Lancet Infectious …, 2023 - thelancet.com
Patients with haematological malignancies might develop life-threatening toxoplasmosis,
especially after allogeneic haematopoietic stem-cell transplantation (HSCT). Reactivation of …

Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant …

RM La Hoz, MI Morris… - Clinical …, 2019 - Wiley Online Library
These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …

A single-parasite transcriptional atlas of Toxoplasma Gondii reveals novel control of antigen expression

Y Xue, TC Theisen, S Rastogi, A Ferrel, SR Quake… - Elife, 2020 - elifesciences.org
Toxoplasma gondii, a protozoan parasite, undergoes a complex and poorly understood
developmental process that is critical for establishing a chronic infection in its intermediate …

Zinc oxide nanoparticles produced by Zingiber officinale ameliorates acute toxoplasmosis-induced pathological and biochemical alterations and reduced parasite …

AM El-Kady, A S. Hassan, K Mohamed… - PLOS Neglected …, 2023 - journals.plos.org
Background Although, approximately 30% of the world's population is estimated to be
infected with Toxoplasma gondii (T. gondii) with serious manifestations in …